tiprankstipranks
FDA clears second bivalent COVID booster for older individuals
The Fly

FDA clears second bivalent COVID booster for older individuals

The Food and Drug Administration today amended the emergency use authorizations of the Moderna (MRNA) and Pfizer (PFE) – BioNTech (BNTX) COVID-19 bivalent mRNA vaccines to "simplify the vaccination schedule for most individuals." The action includes authorizing the current bivalent vaccines to be used for all doses administered to individuals six months of age and older, including for an additional dose or doses for certain populations. The monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States. Most individuals, depending on age, previously vaccinated with a monovalent COVID-19 vaccine who have not yet received a dose of a bivalent vaccine may receive a single dose of a bivalent vaccine. Most individuals who have already received a single dose of the bivalent vaccine are not currently eligible for another dose. Individuals 65 years of age and older who have received a single dose of a bivalent vaccine may receive one additional dose at least four months following their initial bivalent dose, the FDA said in a statement. Reference Link

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on MRNA:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles